doi: 10.1016/j.cgh.2023.03.040.
Epub 2023 Apr 7.
Comparative Effectiveness of Upadacitinib and Tofacitinib in Inducing Remission in Ulcerative Colitis: Real-World Data
Collaborators,
Affiliations
- PMID: 37031712
- DOI: 10.1016/j.cgh.2023.03.040
Item in Clipboard
Comparative Effectiveness of Upadacitinib and Tofacitinib in Inducing Remission in Ulcerative Colitis: Real-World Data
Clin Gastroenterol Hepatol.
2023 Aug.
No abstract available
Similar articles
-
Comparative Efficacy and Safety of Three Janus Kinase Inhibitors in Ulcerative Colitis: A Real-World Multicentre Study in Japan.Aliment Pharmacol Ther. 2025 Feb;61(3):524-537. doi: 10.1111/apt.18406. Epub 2024 Nov 22. Aliment Pharmacol Ther. 2025. PMID: 39578704
-
Efficacy of JAK inhibitors in Ulcerative Colitis.J Crohns Colitis. 2020 Aug 1;14(Supplement_2):S737-S745. doi: 10.1093/ecco-jcc/jjz202. J Crohns Colitis. 2020. PMID: 31879750 Free PMC article. Review.
-
Real-world clinical efficacy of tofacitinib in moderate-to-severe ulcerative colitis.World J Gastroenterol. 2024 Sep 14;30(34):3929-3931. doi: 10.3748/wjg.v30.i34.3929. World J Gastroenterol. 2024. PMID: 39350781 Free PMC article.
-
Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis.Dig Liver Dis. 2020 Mar;52(3):268-273. doi: 10.1016/j.dld.2019.10.003. Epub 2019 Nov 13. Dig Liver Dis. 2020. PMID: 31732444
-
Effectiveness and safety of tofacitinib for the treatment of ulcerative colitis: A single-arm meta-analysis of observational studies.Dig Liver Dis. 2022 Feb;54(2):183-191. doi: 10.1016/j.dld.2021.04.018. Epub 2021 May 16. Dig Liver Dis. 2022. PMID: 34011482
Cited by
-
Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib.Dig Dis Sci. 2024 Oct;69(10):3911-3919. doi: 10.1007/s10620-024-08630-3. Epub 2024 Sep 9. Dig Dis Sci. 2024. PMID: 39251560
-
Are All Janus Kinase Inhibitors for Inflammatory Bowel Disease the Same?Gastroenterol Hepatol (N Y). 2023 Dec;19(12):727-738. Gastroenterol Hepatol (N Y). 2023. PMID: 38404416 Free PMC article.
-
Real-World Comparative Effectiveness and Safety of Filgotinib and Upadacitinib for Ulcerative Colitis: A Multicentre Cohort Study.United European Gastroenterol J. 2024 Dec;12(10):1357-1366. doi: 10.1002/ueg2.12704. Epub 2024 Nov 13. United European Gastroenterol J. 2024. PMID: 39535492 Free PMC article.
-
Upadacitinib Results in Endoscopic Remission in Patients With Inflammatory Bowel Disease and Prior Tofacitinib Failure.J Clin Gastroenterol. 2025 Mar 6:10.1097/MCG.0000000000002157. doi: 10.1097/MCG.0000000000002157. Online ahead of print. J Clin Gastroenterol. 2025. PMID: 40063408
-
Systematic Review with Meta-analysis: Efficacy and Safety of Upadacitinib in Managing Moderate-to-Severe Crohn's Disease and Ulcerative Colitis.Clin Drug Investig. 2024 Jun;44(6):371-385. doi: 10.1007/s40261-024-01364-0. Epub 2024 May 23. Clin Drug Investig. 2024. PMID: 38777970
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
